Aroa Biosurgery ARX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.51

-4.72%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in NZD, from our data supplier.

FY2026

Revenue

NZD 114.9m

FY2017FY2026

Net income

NZD 5.2m

FY2017FY2026

Free cash flow

NZD 10.4m

FY2017FY2026

Shareholders' equity

NZD 82.7m

FY2017FY2026

Income statement

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	NZD 114.9m	NZD 95.9m	NZD 78.9m	NZD 73.9m	NZD 36.9m	NZD 20.5m	NZD 24.3m	NZD 21.8m	NZD 9.7m	—
Gross profit	NZD 99.2m	NZD 82.2m	NZD 67.4m	NZD 62.3m	NZD 28.2m	NZD 14.3m	NZD 17.5m	NZD 13.7m	NZD 4.2m	—
Research and development	NZD 8.8m	NZD 10.8m	NZD 10.5m	NZD 12.4m	NZD 7.8m	NZD 5.9m	NZD 4.5m	NZD 4.1m	NZD 2.9m	—
Operating income	NZD 5.4m	−NZD 10.1m	−NZD 12.2m	−NZD 3.6m	−NZD 7.0m	−NZD 10.3m	−NZD 2.8m	−NZD 179,250	−NZD 2.2m	−NZD 1.0m
Net income	NZD 5.2m	−NZD 4.3m	−NZD 12.1m	−NZD 461,663	−NZD 7.8m	−NZD 17.6m	−NZD 5.7m	NZD 896,261	−NZD 1.2m	−NZD 900,021
Diluted earnings per share	0.01	-0.01	-0.04	-0.00	-0.02	-0.05	-0.01	0.31	-0.17	-0.22

Balance sheet

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Total assets	NZD 100.5m	NZD 98.9m	NZD 126.9m	NZD 135.8m	NZD 104.7m	NZD 73.1m	NZD 44.5m	NZD 38.0m	NZD 14.3m	NZD 8.1m
Cash and short-term investments	NZD 22.6m	NZD 20.1m	NZD 34.5m	NZD 53.6m	NZD 53.4m	NZD 33.9m	NZD 42.4m	NZD 4.3m	NZD 3.6m	—
Total liabilities	NZD 17.7m	NZD 14.3m	NZD 18.4m	NZD 17.1m	NZD 11.3m	NZD 19.4m	NZD 19.7m	NZD 26.4m	NZD 12.5m	NZD 292,292
Debt	NZD 5.3m	NZD 5.8m	NZD 8.5m	NZD 8.8m	NZD 5.8m	NZD 15.4m	NZD 10.8m	NZD 1.1m	NZD 1.5m	—
Shareholders' equity	NZD 82.7m	NZD 84.6m	NZD 108.5m	NZD 118.8m	NZD 93.4m	NZD 53.7m	NZD 62.9m	NZD 11.5m	NZD 1.8m	NZD 7.8m
Shares outstanding	359m	382m	342m	344m	343m	363m	486m	3m	7m	4m

Cash flow

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash from operations	NZD 11.7m	−NZD 2.9m	−NZD 8.4m	−NZD 4.4m	−NZD 10.7m	−NZD 5.0m	NZD 1.6m	−NZD 6,535	−NZD 2.8m	−NZD 917,968
Capital spending	−NZD 1.2m	−NZD 4.2m	−NZD 4.0m	−NZD 8.9m	−NZD 4.5m	−NZD 1.4m	−NZD 1.8m	−NZD 1.5m	−NZD 1.6m	−NZD 50,895
Free cash flow	NZD 10.4m	−NZD 7.1m	−NZD 12.4m	−NZD 13.3m	−NZD 15.2m	−NZD 6.4m	−NZD 199,537	−NZD 1.5m	−NZD 4.4m	−NZD 968,863
Dividends paid	—	—	—	—	−NZD 0	−NZD 18.2m	—	—	—	—

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	15.9%	41.2%	63.4%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	86.0%	85.6%	84.0%	—
Operating margin	-2.2%	-5.6%	-9.0%	—
Net margin	0.4%	-3.2%	-8.8%	—

Valuation history

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Price to earnings	42.3	-78.7	-25.4	-753.0	-57.5	-25.2	-120.7
Price to sales	1.9	3.5	3.9	4.7	12.2	21.7	28.1

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Aroa Biosurgery ARX.AX · AUD

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Growth per year

Average margins

Valuation history

Sources and methodology